Peptides for Recovery & Longevity: BPC-157, TB-500, GHK-Cu & More (2026)

What Are Therapeutic Peptides?

Peptides are short chains of amino acids — smaller than proteins, larger than individual amino acids. The body uses thousands of endogenous peptides as signaling molecules: hormones (insulin, GLP-1, oxytocin), growth factors, cytokines, and antimicrobial peptides are all peptides. Therapeutic peptides are either naturally occurring peptides or synthetic analogs designed to mimic or modulate specific biological processes.

The last decade has seen explosive growth in peptide research and biohacker adoption. Unlike anabolic steroids (which are synthetic androgens with broad hormonal effects), most therapeutic peptides are highly targeted — acting on specific receptors or pathways with narrower systemic effects. This specificity is their appeal and their limitation.

Important Regulatory Note: Many peptides discussed here are legal to possess but are not FDA-approved for human use (they may be approved for research purposes only). BPC-157 and TB-500, for example, are widely used in the biohacking community but are not pharmaceutical products. Some were removed from compound pharmacy availability in the US in 2024. Always consult a physician before using any peptide, and source from reputable vendors with third-party testing.

BPC-157: Body Protective Compound

BPC-157 (Body Protective Compound 157) is a synthetic pentadecapeptide — a 15-amino-acid sequence derived from a protein naturally found in human gastric juice. It was first isolated and studied by Croatian researcher Predrag Sikiric in the 1990s and has been the subject of extensive animal research, though human clinical trials remain limited.

Mechanisms of Action

BPC-157 appears to work through multiple mechanisms:

Angiogenesis promotion: Upregulates VEGF (vascular endothelial growth factor), accelerating new blood vessel formation critical for tissue repair
Nitric oxide modulation: Activates the NO pathway, improving blood flow to injured tissue
Growth hormone receptor sensitization: May amplify local GH signaling without increasing systemic GH levels
Tendon and ligament healing: Upregulates tendon fibroblast activity and collagen synthesis
Gut mucosal protection: Its origin in gastric juice suggests potent gastroprotective effects — animal studies show it heals intestinal fistulas, reduces inflammatory bowel disease markers, and protects against NSAID-induced gut damage

What the Evidence Shows

The majority of BPC-157 research is in rodent models — where it is consistently impressive. Studies show accelerated healing of Achilles tendon transections, rotator cuff injuries, bone fractures, muscle tears, corneal wounds, and intestinal anastomoses. The effect sizes in animal models are remarkable — often 50–100% faster healing than controls.

Human data is largely anecdotal, though two small human trials (using it systemically for inflammatory bowel disease) showed safety and tolerability. The biohacker community reports widespread subjective benefit for injury recovery, particularly for tendons and ligaments that are traditionally very slow to heal.

Forms and Dosing

BPC-157 is available in two forms:

Injectable (subcutaneous or intramuscular): Most common biohacker protocol; 250–500 mcg daily, injected near the injury site when possible. Requires pharmaceutical-grade lyophilized powder and reconstitution with bacteriostatic water.
Oral capsules: Less bioavailable systemically but may be appropriate for gut-specific applications (IBD, leaky gut, NSAID damage). Dose typically 500 mcg–2 mg orally.

TB-500: Thymosin Beta-4 Fragment

TB-500 is a synthetic fragment of Thymosin Beta-4 (TB4), a naturally occurring peptide found in virtually all human cells and particularly concentrated in platelets and wound fluid. TB4 is a key regulator of actin polymerization — fundamental to cell migration, muscle fiber repair, and wound healing.

What It Does

Actin regulation: Sequesters G-actin, regulating cytoskeletal dynamics in repair cells (fibroblasts, myoblasts, keratinocytes) that migrate to injury sites
Anti-inflammatory: Reduces pro-inflammatory cytokines (TNF-alpha, IL-1beta) at injury sites
Stem cell activation: Appears to mobilize progenitor cells from bone marrow to injury sites
Cardiac repair: The most clinically advanced application — TB4 has been studied in human Phase I/II trials for cardiac repair after myocardial infarction

TB-500 (the fragment of TB4 that is sold commercially) retains the actin-binding and anti-inflammatory properties of the full molecule. Most biohacker usage is for injury recovery — particularly muscle, tendon, and ligament healing alongside BPC-157.

Dosing

Common protocol: 2–2.5 mg twice weekly for 4–6 weeks (loading phase), then 2 mg monthly for maintenance. Injectable subcutaneously. Often stacked with BPC-157 for synergistic tissue repair effects.

GHK-Cu: Copper Peptide

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding peptide found in human plasma, urine, and saliva. It was first identified by Loren Pickart in 1973 and has been studied for over 50 years — with a substantial body of research compared to newer peptides.

Blood GHK levels are highest in young adults and decline with age — from approximately 200 ng/mL at age 20 to under 80 ng/mL by age 60 — mirroring the age-related decline in tissue regenerative capacity that it partially regulates.

Mechanisms

Collagen synthesis: Activates fibroblasts and upregulates collagen types I, II, and III; also upregulates fibronectin and glycosaminoglycans
Wound healing: Widely demonstrated in multiple cell types and tissue models; accelerates epithelialization, contraction, and vascularization
Anti-inflammatory gene expression: GHK-Cu modulates expression of over 4,000 human genes (per Loren Pickart's microarray analyses), with an anti-inflammatory and antioxidant bias
Skin remodeling: The best-established human application — topical GHK-Cu serum is used widely in cosmetic dermatology to reduce wrinkles, improve skin laxity, and accelerate wound healing
Nervous system: May support nerve regeneration and protect neurons — animal studies show GHK-Cu helps reverse cognitive decline and oxidative damage in the brain

Forms and Applications

Topical (skin): Best-documented human application. GHK-Cu serums and creams have multiple RCTs supporting skin rejuvenation benefits. Used at 0.1–10% concentration in cosmetic formulations.
Subcutaneous injection: Used by biohackers for systemic anti-aging and recovery effects; typical dose 1–3 mg several times per week. Evidence is primarily preclinical.
Scalp application: Animal studies and preliminary human data suggest GHK-Cu promotes hair follicle growth — used in some hair loss treatments.

Other Notable Research Peptides

Epithalon (Epitalon)

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Russian gerontologist Vladimir Khavinson. Stimulates telomerase activity and has demonstrated life extension in animal models. Some human studies (primarily Russian literature) show improved melatonin secretion, reduced cancer incidence, and extended lifespan markers. Interesting but evidence quality is limited outside Russia.

Selank

A synthetic analog of the naturally occurring immunomodulatory peptide tuftsin. Developed by the Russian Academy of Sciences. Shows anxiolytic (anti-anxiety) effects comparable to benzodiazepines in animal models without dependence risk. Used clinically in Russia for generalized anxiety disorder and mild cognitive impairment. Evidence quality is moderate.

PT-141 (Bremelanotide)

A synthetic melanocortin peptide that acts on MC3R and MC4R receptors in the brain to increase sexual arousal and function. Notably, it is FDA-approved (as Vyleesi) for hypoactive sexual desire disorder in premenopausal women — making it one of the few therapeutic peptides with FDA approval. Used off-label by men for erectile dysfunction that doesn't respond to PDE5 inhibitors.

Topical GHK-Cu Products (Consumer-Accessible)

Note: Injectable peptides (BPC-157, TB-500) are not sold as retail supplements on Amazon. We focus here on topical GHK-Cu products that are legally available as skincare. For injectable peptide information, consult a functional medicine physician or licensed compounding pharmacy.

Safety, Sourcing, and Legal Status

Is Peptide Use Safe?

The most studied peptides (GHK-Cu topically, PT-141 FDA-approved) have established safety profiles. For injectable BPC-157 and TB-500, animal safety data is excellent and human adverse event reports are rare, but systematic human safety data is limited. The main risks are:

Infection risk from injection: Requires sterile technique; use alcohol-swabbed vials and subcutaneous injection protocol
Unknown long-term effects: Most peptides lack 10+ year human safety data
Theoretical oncology concerns: Growth-promoting peptides (BPC-157's angiogenic effects) could theoretically accelerate growth of occult tumors — a theoretical concern lacking clinical evidence but worth noting for individuals with cancer history
Quality control: The research chemical market has significant variability in purity and accurate dosing

Sourcing Considerations

For those pursuing injectable peptide therapy, the hierarchy of sourcing safety is: (1) compounding pharmacy with valid prescription from a physician — the only FDA-compliant US route; (2) licensed international pharmacies; (3) research chemical vendors with third-party COA (certificate of analysis) for each batch. Never use a vendor who doesn't provide batch-specific mass spectrometry verification.

The Bottom Line

Peptide therapy sits at the frontier of longevity and recovery medicine — backed by compelling mechanistic science and strong animal data, with human evidence still accumulating. GHK-Cu topically is the most evidence-backed and accessible application. BPC-157 and TB-500 have a strong pre-clinical foundation and widespread anecdotal success for injury recovery, but human RCTs are needed. Those pursuing injectable protocols should do so under physician supervision with quality-verified sourcing.